Acrivastine and pseudoephedrine and Ogen 1.25
Determining the interaction of Acrivastine and pseudoephedrine and Ogen 1.25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: estropipate
Brand name: Ogen 125, Ortho-Est, Ogen 0625, Ogen 25
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Ogen Cream
- Acrivastine and pseudoephedrine-Ogestrel
- Acrivastine and pseudoephedrine-Ogestrel 0.5/50
- Acrivastine and pseudoephedrine-Ogestrel-28
- Acrivastine and pseudoephedrine-Ogivri
- Acrivastine and pseudoephedrine-Ogivri Injection
- Ogen 1.25-Actamin
- Ogen 1.25-Actamin Maximum Strength
- Ogen 1.25-Actemra
- Ogen 1.25-Actemra (Tocilizumab (Intravenous))
- Ogen 1.25-Actemra (Tocilizumab Auto-Injectors)
- Ogen 1.25-Actemra (Tocilizumab Prefilled Syringes)